A team at Institute of Biochemistry and Cell Biology in Shanghai has claimed that it is the first to achieve this in hoofed animals, which can also help in cloning pigs which are disease-free.

According to the scientists, induced pluripotent stem (iPS) cells have the potential to turn into all types of body tissue. And, the big advantage is that they can be genetically manipulated in the lab, and then cloned to create animals with new traits.

By adding or deleting certain genes, the scientists could produce pigs whose organs can be transplanted into human patients without them being recognised and rejected, the 'New Scientist' reported.

Lead researcher Lei Xiao said: "The pig species is significantly similar to humans in its form and function, and the organ dimensions are largely similar to human organs.

"We could use these cells to modify the immune-related genes in the pig to make the pig organ compatible to the human immune system. Then we could use these pigs as (organ sources) that won't trigger an adverse reaction from the patient's own immune system."

According to the scientists, they have made the iPS cells by using a virus to load ear or bone marrow cells with special reprogramming factors. These "rewound" the cells to the embryonic-like state of iPS cells.

As well as working towards improved organs for xenotransplantation, the team intends to produce pigs that are resistant to diseases, including swine flu.

"We could do this by finding and manipulating a gene that has anti-swine flu activity, or which inhibits growth of the swine flu virus," said Xiao, whose study has appeared in the latest edition of the 'Journal of Molecular Cell Biology'.

Experts have welcomed the research. Chris Mason, an expert in regenerative medicine at University College London, said the breakthrough will boost the quest for "humanised" pig organs.

"While (using pig organs) may not necessarily be the long-term solution, it may represent a major step change in the treatment of organ failure, which potentially could deliver real benefit to millions of patients within a decade," he said.